The Put Option Agreement was previously disclosed by Psyence BioMed and forms part of the broader strategic and commercial relationship between the two vertically integrated companies, including ...
PARIS--(BUSINESS WIRE)--Regulatory News: The holders of the 2028 Notes 1 and the 2031 Notes 2 issued by Verallia (Paris:VRLA) have been informed through a notice published on 1 August 2025 (the “Put ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results